Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance.
- NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_assertion description "[There is evidence to suggest that follicle-stimulating hormone (FSH) can facilitate the neovascularization of ovarian cancers by increasing vascular endothelial growth factor (VEGF) expression in cancer cells, although the underlying molecular mechanism of this process is not well known.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance.
- NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_assertion evidence source_evidence_literature NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance.
- NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_assertion SIO_000772 18574502 NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance.
- NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_assertion wasDerivedFrom befree-20140225 NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance.
- NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_assertion wasGeneratedBy ECO_0000203 NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP598938.RA_0eu2VSEbXrQKNRbDwbukA0mHcRm_XYpLnb-W8XCGKA130_provenance.